October 11, 2007KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model

August 28, 2007KineMed to Collaborate With Merck KGaA to Validate New Applications for Drug Development Candidates

August 14, 2007KineMed Extends Alliance with CMIC in Japanese Market

August 7, 2007KineMed and Merck Enter Collaboration in Atherosclerosis

August 3, 2007KineMed Completes $15 Million Offering of Convertible Notes Funds Will Support Advancement of Lead Program into Clinical Testing in 2008

May 21, 2007KineMed Evaluates the Mechanism of Action for Colesevelam in Patients With Type 2 Diabetes

May 10, 2007KineMed Acquires Option to Exclusively License Patents Covering SR-B1 as a Target for Atherosclerotic Heart Disease from Massachusetts Institute of Technology

May 10, 2007KineMed Presents Data Measuring Changes in Reverse Cholesterol Transport for the First Time

March 1, 2007KineMed and Roche Enter Collaboration to Validate Translational KineMarker Technology in Fibrosis

February 6, 2007KineMed and Bayer Healthcare AG Enter Collaboration to Discover New Therapeutic Applications for Drug Candidates